Company: CERO
Filing Date: 2025-11-28
Form Type: DEF 14A
Source: 0001213900-25-115783
Chunk: 80

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-28
Form: DEF 14A
Chunk 80
---
 be adjusted so that the aggregate exercise price shall be the same immediately before and immediately after any such adjustment. However, unlike the Series A Warrants and Series C Warrants, the warrants issued on December 23, 2024 are not subject to any exercise price reduction or adjustment relating to the timing of stockholder approval thereof or the pricing of any future offering. Warrants Issued on January 6, 2025 Except as set forth below, such warrants have terms and provisions that are substantially the same as those of the Series A Warrants. Exercise Price.The warrants issued on January 6, 2025 (the “January 2025 Warrants”) will initially be exercisable for cash at an exercise price equal to $116.40. The exercise price is subject to adjustment for stock splits, combinations and similar events, and, in the event of stock dividends and splits, the number of shares of Common Stock issuable upon the exercise of such warrant will also be adjusted so that the aggregate exercise price shall be the same immediately before and immediately after any such adjustment. However, unlike the Series A Warrants and Series C Warrants, the warrants issued on January 6, 2025 are not subject to any exercise price reduction or adjustment relating to the timing of stockholder approval thereof or the pricing of any future offering. 43 Warrants Issued on February 7, 2025 On February 7, 2025, we issued and sold 15,000shares of our Common Stock and 112,551 February 2025 Pre -FundedWarrants to purchase 112,551shares of our Common Stock together with 112,551 February 2025 Common Warrants to purchase 127,551shares of Common Stock. Each share of Common Stock or Pre -FundedWarrant was sold together with a February 2025 Common Warrant to purchase one share of Common Stock. The shares of Common Stock or February 2025 Pre -FundedWarrants and accompanying February 2025 Common Warrants were issued separately and were immediately separable upon. February 2025 Pre-Funded Warrants The following summary of certain terms and provisions of the February 2025 Pre -FundedWarrants is not complete and is subject to, and qualified in its entirety by, the provisions of the February 2025 Pre -FundedWarrant, the form of which is filed as Exhibit No. 4.8 to the registration statement filed with the SEC on February 5, 2025.